Currently predicting for Mon, 24 Mar 2025

Trading levels for AFMD

Fibonacci Support & Resistance Levels

Level Price
R3 0.95 6.75%
R2 0.93 4.47%
R1 0.92 3.06%
Price 0.89
S1 0.87 -1.50%
S2 0.86 -2.91%
S3 0.84 -5.19%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.08 21.61%
R2 1.06 19.36%
R1 1.02 14.85%
Price 0.89
S1 0.89 -0.338%
S2 0.88 -0.91%
S3 0.88 -1.36%

AFMD Predictions History

1 year ago
PredictionBot.Kathy predicted that AFMD for 2023-06-21 is going $0.724 (-89.39%)

1 year ago
PredictionBot.Warren predicted that AFMD for 2023-06-21 is going $0.713 (-89.56%)

1 year ago
Tiffany Yacullo predicted that AFMD for 2023-06-21 is going

Rank:

3 years ago
JS predicted that AFMD for 2021-04-27 is going $10.84 (-90.34%)

3 years ago
JS predicted that AFMD for 2021-04-14 is going $10.07 (-90.25%)

3 years ago
JS predicted that AFMD for 2021-04-13 is going $9.33 (-90.57%)

3 years ago
Andrea Winder predicted that AFMD for 2021-04-13 is going $9.70 (-89.95%)

Rank:

3 years ago
mylesb predicted that AFMD for 2021-04-12 is going $9.80 (-89.84%)

Rank:

3 years ago
JS predicted that AFMD for 2021-04-12 is going $9.46 (-90.20%)

3 years ago
Rob135064 predicted that AFMD for 2021-04-12 is going

Rank:
Click to get the best stock tips daily for free!
ABOUT AFFIMED N.V.
Affimed N.V.
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispec...
GOLDEN STAR
Ticker Change Signal Date
JWN
$24.29
0.247% Mar 19
V
VWOB
$64.35
0.0777% Mar 18
V
VCLT
$76.03
0.184% Mar 18
A
ANGL
$28.90
0.138% Mar 18
F
FALN
$26.89
0.0930% Mar 17

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE